Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Medarex Inc



Medarex Inc (MEDX:US) was acquired by BMY:US

Company Profile

Medarex,Inc. is a biopharmaceutical company developing antibody-based therapeutics to fight cancer and life-threatening and debilitating diseases. The Company has several products in clinical development for the treatment of cancers and leukemia, autoimmune diseases, and ophthalmic conditions. Medarex also creates and develops human antibodies for itself and others.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...
sec ||= nil